Skip to main content
Fig. 1 | Hereditary Cancer in Clinical Practice

Fig. 1

From: Germline heterozygous exons 8–11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding?

Fig. 1

Multiplex Ligation-Dependent Probe Amplification (MLPA) analysis: One hundred nanograms of genomic DNA of the proband and his relatives were analyzed for CNV confirmation/detection in BARD1 gene with SALSA MLPA P489 probemix (MRC Holland, Amsterdam, The Netherlands) according to manufacturer’s instructions on an ABI3500 Genetic Analyzer (Thermo Fisher Scientific). Data were analyzed with Coffalyser.NET software (MRC Holland)

Back to article page

Hereditary Cancer in Clinical Practice

ISSN: 1897-4287